Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancerAntonino Musolino, Maria Michiara, Angelica Sikokis et al.|Critical Reviews in Oncology/Hematology|2020Cited by 21
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry studyAntonino Musolino, Maria Michiara, Fabio Falcini et al.|European Journal of Cancer|2017Cited by 3